Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P581.

5-ASA medication adherence comparison in Latvia and Estonia

Authors:

E. Krustins, V. Mokricka, J. Pokrotnieks, A. Pukitis, Pauls Stradins Clinical University Hospital, Centre of Gastroenterology, Hepatology and Nutrition, Riga, Latvia

P581. Baseline clinical activity index appears to predict clinical and endoscopic response in patients with ulcerative colitis undergoing intensive granulocyte and monocyte apheresis
Authors:

A. Aisaka1, B. Iiduka1, A. Ito1, M. Takahashi1, T. Ohmori1, M. Yonezawa1, 1Tokyo Women's Medical University Hospital, Gastroenterology, Tokyo, Japan

P581

A Pharmacokinetic Study of Ferric Maltol (ST10; Fe-M) at 3 Dosages in Inflammatory Bowel Disease (IBD) Patients with Iron Deficiency

Authors:

B. Bokemeyer*1, A. Krummenerl2, C. Maaser3, S. Howaldt4, M. Mroß5, N. Mallard6

1Gastroenterology Practice Minden, Gastroenterology , Minden, Germany, 2Krankenhaus Martha-Maria Halle-Dölau, Studienambulanz, Klinik für Innere Medizin I, Halle (Saale), Germany, 3Städtisches Klinikum Lüneburg gGmbH, Leitung Ambulanzzentrum Gastroenterologie am Klinikum Lüneburg, Lüneburg, Germany, 4Hamburgisches Forschungsinstitut für CED, HaFCED GmbH&Co. KG, Hamburg, Germany, 5Gastroenterologische Spezialpraxis, Gastroenterologische, Berlin, Germany, 6Iron Therapeutics (UK) Ltd, Clinical Development, Gateshead, United Kingdom

P582.

Remission induction therapy with infliximab in patients with ulcerative colitis: Does tumour necrosis factor-α blockade per se explain its multiple actions?

Authors:

M. Kawai1, Y. Yokoyama1, K. Kamikozuru1, K. Nagase1, M. Iimuro1, H. Miwa2, S. Nakamura1, 1Hyogo College of Medicine, Internal Medicine, Lower Gastroenterology, Nishinomiya, Japan, 2Hyogo College of Medicine, Internal Medicine, Upper gastroenterology, Nishinomiya, Japan

P582. Azathioprine therapy in Crohn's disease patients: a 16-year cohort analysis
Authors:

A.M. Oliveira1, C. Rodrigues1, F. Cardoso1, L. Ricardo1, S. Alberto1, L. Santos1, D. Horta1, A. Martins1, J. Reis1, J.R. Deus1, 1Hospital Prof. Doutor Fernando Fonseca, Portugal

P582

Serological monitoring for HBV infection and response to vaccination in Greek patients with IBD: a multi-centre study

Authors:

D. Calogera1, E. Zampeli2, E. Tsironi3, M. Tzouvala4, A. Kostas1, E. Kourkoutas2, S. Siakavellas1, K. Filippakou3, J. Vlachogiannakos1, S. Michopoulos2, G. Papatheodoridis1, G. Bamias*1

1Kapodistrian University of Athens, Laikon Hospital, Academic Department of Gastroenterology, Athens, Greece, 2Alexandra General Hospital, Gastroenterology Department, Athens, Greece, 3Metaxa Memorial Cancer Hospital, Gastroenterology Department, Piraeus, Greece, 4'St. Panteleimon' Nikaia General Hospital, Gastroenterology Department, Piraeus, Greece

P583.

Venous thromboembolism in Asian patients with inflammatory bowel disease

Authors:

H. Lin, W.C. Lim, Tan Tock Seng Hospital, Gastroenterology and Hepatology, Singapore, Singapore

P583. Attitudes to smoking in people with Crohn's disease
Authors:

H. Sathanapally1, A. Wilson1, T. Moshkovska1, J. Mayberry1, 1University of Leicester, Leicester, United Kingdom

P583

Sequential Change of Endoscopic Findings and Therapeutic Efficacy of Anti-TNF alpha therapy for Patients with Intestinal Behçet's Disease

Authors:

Y. Hirayama*1, 2, O. Watanabe1, M. Nakamura1, T. Yamamura1, H. Goto1

1Nagoya University Graduate School of Medicine, Departmant of Gastroenterology and Hepatology, Nagoya, Japan, 2Tokai Central Hospital, Department of Endoscopy, Kakamigahara, Japan

P584.

Vaccination and risk for inflammatory bowel disease: results of a meta-analysis

Authors:

G. Pineton de Chambrun1, L. Dauchet2, C. Gower-Rousseau2, A. Cortot1, J.-F. Colombel3, L. Peyrin-Biroulet4, 1Lille University Hospital, North of France University, Gastroenterology, Lille, France, 2Lille University Hospital, North of France University, Epidemiology, Lille, France, 3Mount Sinai Hospital, Gastroenterology, New-York, United States, 4Nancy University Hospital, Université de Lorraine, Gastroenterology and Hepatology, Vandoeuvre-les-Nancy, France

P584. A study evaluating clinicians' attitudes and preferences for a web-based IBD patient portal designed to facilitate self-management
Authors:

C. Calvert1, S. Lal2, C. Stansfield2, J. McLaughlin1, A. Robinson2, 1Manchester University, School of Translational Medicine, Manchester, United Kingdom, 2Salford Royal Foundation Trust, Gastroenterology, Salford, United Kingdom

P584

Infliximab therapy for Japanese patients with ulcerative colitis: Efficacy, safety, and association between serum infliximab levels and early response in a randomized, double-blind, placebo-controlled study

Authors:

Y. Suzuki*1, S. Motoya2, F. Hirai3, H. Ogata4, H. Ito5, N. Sato6, K. Ozaki7, M. Watanabe8, T. Hibi9

1Toho University Sakura Medical Center, Department of Internal Medicine, Sakura, Japan, 2Sapporo-kosei General Hospital, Inflammatory Bowel Diseases Center, Sapporo, Japan, 3Fukuoka University Chikushi Hospital, Department of Gastroenterology, Chikushino, Japan, 4Keio University School of Medicine, Center for Diagnostic and Therapeutic Endoscopy, Tokyo, Japan, 5Kitano Hospital The Tazuke Kofukai Medical Research Institute, Digestive Disease Center, Osaka, Japan, 6Mitsubishi Tanabe Pharma Corporation, Pharmacovigilance & Quality Assurance Division, Osaka, Japan, 7Mitsubishi Tanabe Pharma Corporation, Development Division, Tokyo, Japan, 8Tokyo Medical and Dental University, Department of Gastroenterology and Hepatology, Tokyo, Japan, 9Kitasato University Kitasato Institute Hospital, Center for Advanced IBD Research and Treatment, Tokyo, Japan

P585.

Treatment paradigm and natural course of ulcerative colitis between 1977–2012: a hospital-based cohort study from Korea

Authors:

S.-J. Myung, S.H. Park, S. Lee, S.-K. Yang, J.-S. Byeon, K.-J. Kim, B.D. Ye, D.-H. Yang, K.W. Jung, J.-H. Kim, J.-B. Kim, H.-S. Lee, H.J. Lee, S.-K. Park, University of Ulsan College of Medicine, Asan Medical Center, Gastroenterology, Seoul, South Korea

P585. Association between thiopurines metabolites levels and clinical remission in IBD patients: an updated meta-analysis
Authors:

A. Moreau1, S. Laporte1, E. Del Tedesco1, M. Rinaudo-Gaujous1, J.M. Phelip1, S. Paul1, X. Roblin1, 1University of Saint Etienne, Saint Etienne, France

P585

Preventing Crohn's Disease recurrence after resection with adalimumab: Role of drug and anti-drug antibody levels

Authors:

E. Wright*1, M. Kamm1, 2, F. Selvaraj3, F. Princen3, P. De Cruz1, A. Hamilton1, K. Ritchie1, E. Krejany1, A. Gorelik1, D. Liew1, L. Prideaux1, I. Lawrance1, J. Andrews1, P. Bampton1, S. Jakobovits1, T. Florin1, P. Gibson1, H. Debinski1, R. Gearry1, F. Macrae1, D. Samuel1, I. Kronborg1, G. Radford-Smith1, W. Selby1, M. Johnston1, R. Woods1, P.R. Elliott1, S. Bell1, S. Brown1, W. Connell1, P. Desmond1, S. Singh3

1St Vincent's Hospital & University of Melbourne, Gastroenterology, Melbourne, Australia, 2Imperial College London, Medicine, London, United Kingdom, 3Prometheus Laboratories, Department of Research and Development, San Diego, United States

P586.

Time-to-diagnosis in inflammatory bowel disease

Authors:

G. Can, A. Tezel, G. Ünsal, A. Üstündag, H. Ümit, A.R. Soylu, Trakya University Faculty of Medicine, Gastroenterology Department, Edirne, Turkey

P586. Assessment of pregnancy-specific inflammatory bowel disease (IBD) knowledge, attitudes and experience in Australian obstetricians and gynaecologists (O&G)
Authors:

M. Roberts1, C. Selinger2, R. Leong3, J. Andrews4, 1Royal Adelaide Hospital, Adelaide, Australia, 2University of Manchester, School of Translational Medicine, Manchester, United Kingdom, 3Concord Hospital and University of Sydney, Department of Gastroenterology and Hepatology, Sydney, Australia, 4Royal Adelaide Hospital and University of Adelaide, Department of Gastroenterology and Hepatology, Adelaide, Australia

P586

Paradoxical psoriasis in a large cohort of IBD patients treated with anti-TNF alpha: 5 years-follow-up study

Authors:

D. Pugliese*1, P.M. Ferraro2, M. Marzo1, C. Felice1, L. Celleno3, R. Landi1, G. Andrisani1, F. Pizzolante1, A. Papa1, I. De Vitis1, G. Rapaccini1, L. Guidi1, A. Armuzzi1

1Complesso Integrato Columbus, Catholic Univeristy, IBD Unit, Internal Medicine and Gastroenterology, Rome, Italy, 2Complesso Integrato Columbus, Catholic University, Nefrology, Rome, Italy, 3Complesso Integrato Columbus, Catholic Univeristy, Dermatology, Rome, Italy

P587.

The prevalence of anaemia and iron deficiency in IBD inpatients and outpatients in Romania – an interim analysis on the first 120 patients

Authors:

A. Goldis1, M. Tantau2, L. Gheorghe3, C. Gheorghe3, M. Diculescu3, 1University of Medicine Timisoara, Gastroenterology, Timisoara, Romania, 2University of Medicine Cluj-Napoca, Gastroenterology, Cluj-Napoca, Romania, 3University of Medicine Bucharest, Gastroenterology, Bucharest, Romania

P587. Assessing how IBD patients see themselves? Validation and first use of a targeted body image instrument
Authors:

E. McDermott1, G. Mullen2, D. Keegan1, K. Byrne1, G. Doherty1, G. Cullen1, K. Malone3, H. Mulcahy1, 1St Vincent's University Hospital, Centre for Colorectal Disease, Dublin, Ireland, 2University College Dublin, Department of Clinical Psychology, Dublin, Ireland, 3St Vincent's University Hospital, Department of Psychiatry, Dublin, Ireland